Artem Khan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Artem Khan has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Kıvanç Birsoy
Laboratory of Metabolic Regulation and Genetics, The Rockefeller University, New York, NY, USA
16 shared publications - Gokhan Unlu
Laboratory of Metabolic Regulation and Genetics, The Rockefeller University, New York, USA
13 shared publications - Beste Uygur
Laboratory of Metabolic Regulation and Genetics, The Rockefeller University, New York, USA
12 shared publications - Rebecca C. Timson
Laboratory of Metabolic Regulation and Genetics, The Rockefeller University, New York, New York
12 shared publications - Richard Possemato
Department of Pathology, New York University Grossman School of Medicine, New York, NY 10016, USA
11 shared publications - Albert Sickmann
Leibniz-Institut für Analytische Wissenschaften - ISAS - e.V., Dortmund, Germany
10 shared publications
Latest Publications
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from Mitochondrial Glutathione Import Enables Breast Cancer Metastasis via Integrated Stress Response Signaling
Mitochondrial profiling reveals context-specific features of breast cancer cells in primary tumors and metastases
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Mitochondrial Glutathione Import Enables Breast Cancer Metastasis via Integrated Stress Response Signaling
Mitochondrial profiling reveals context-specific features of breast cancer cells in primary tumors and metastases
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S3 from Mitochondrial Glutathione Import Enables Breast Cancer Metastasis via Integrated Stress Response Signaling
SLC25A39-mediated mitochondrial GSH import is essential for metastasis but dispensable for primary tumor growth
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Mitochondrial Glutathione Import Enables Breast Cancer Metastasis via Integrated Stress Response Signaling
SLC25A39-mediated mitochondrial GSH import is essential for metastasis but dispensable for primary tumor growth
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S5 from Mitochondrial Glutathione Import Enables Breast Cancer Metastasis via Integrated Stress Response Signaling
Antioxidant supplementation fails to rescue metastatic defects caused by SLC25A39 loss
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Mitochondrial Glutathione Import Enables Breast Cancer Metastasis via Integrated Stress Response Signaling
Antioxidant supplementation fails to rescue metastatic defects caused by SLC25A39 loss
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S2 from Mitochondrial Glutathione Import Enables Breast Cancer Metastasis via Integrated Stress Response Signaling
In vivo CRISPR screening of breast cancer cell lines during metastasis
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Mitochondrial Glutathione Import Enables Breast Cancer Metastasis via Integrated Stress Response Signaling
In vivo CRISPR screening of breast cancer cell lines during metastasis
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S6 from Mitochondrial Glutathione Import Enables Breast Cancer Metastasis via Integrated Stress Response Signaling
ATF4 overexpression bypasses the requirement for mitochondrial GSH during metastasis
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from Mitochondrial Glutathione Import Enables Breast Cancer Metastasis via Integrated Stress Response Signaling
ATF4 overexpression bypasses the requirement for mitochondrial GSH during metastasis
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Table S1 from Mitochondrial Glutathione Import Enables Breast Cancer Metastasis via Integrated Stress Response Signaling
Primers and DNA oligos used in this study
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Mitochondrial Glutathione Import Enables Breast Cancer Metastasis via Integrated Stress Response Signaling
Primers and DNA oligos used in this study
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Table S2 from Mitochondrial Glutathione Import Enables Breast Cancer Metastasis via Integrated Stress Response Signaling
Antibodies and reagents used in study
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Mitochondrial Glutathione Import Enables Breast Cancer Metastasis via Integrated Stress Response Signaling
Antibodies and reagents used in study
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Data from Mitochondrial Glutathione Import Enables Breast Cancer Metastasis via Integrated Stress Response Signaling
Cancer cells require substantial metabolic adaptations to metastasize to distant organs, but the metabolites essential for successful colonization remain poorly defined. In this study, we used a mitochondrial metabolomics approach to compare primary and metastatic breast cancer cells. This analysis revealed accumulation of mitochondrial glutathione (GSH) during lung metastasis, driven by elevated expression of SLC25A39, a mitochondrial GSH transporter. Loss of SLC25A39 impairs metastatic colonization in genetic screens, cell line models, and patient-derived xenografts, without affecting primary tumor growth. Mitochondrial GSH import is specifically required during early colonization and functions independently of its canonical antioxidant role. CRISPR activation screens identified ATF4, a stress-induced transcription factor, as a bypass mechanism that restores metastatic potential in SLC25A39-deficient cells. Mechanistically, SLC25A39 is required for optimal ATF4 activation during metastasis and under hypoxia, linking mitochondrial GSH availability to integrated stress response signaling. These findings identify mitochondrial GSH as a necessary and limiting metabolite for metastatic progression.Significance:Mitochondrial GSH import via SLC25A39 is essential for early metastatic colonization in breast cancer, linking metabolic adaptation to stress response signaling. Targeting this pathway may uncover a therapeutic vulnerability specific to metastasis without affecting primary tumor growth.
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Mitochondrial Glutathione Import Enables Breast Cancer Metastasis via Integrated Stress Response Signaling
Cancer cells require substantial metabolic adaptations to metastasize to distant organs, but the metabolites essential for successful colonization remain poorly defined. In this study, we used a mitochondrial metabolomics approach to compare primary and metastatic breast cancer cells. This analysis revealed accumulation of mitochondrial glutathione (GSH) during lung metastasis, driven by elevated expression of SLC25A39, a mitochondrial GSH transporter. Loss of SLC25A39 impairs metastatic colonization in genetic screens, cell line models, and patient-derived xenografts, without affecting primary tumor growth. Mitochondrial GSH import is specifically required during early colonization and functions independently of its canonical antioxidant role. CRISPR activation screens identified ATF4, a stress-induced transcription factor, as a bypass mechanism that restores metastatic potential in SLC25A39-deficient cells. Mechanistically, SLC25A39 is required for optimal ATF4 activation during metastasis and under hypoxia, linking mitochondrial GSH availability to integrated stress response signaling. These findings identify mitochondrial GSH as a necessary and limiting metabolite for metastatic progression.Significance:Mitochondrial GSH import via SLC25A39 is essential for early metastatic colonization in breast cancer, linking metabolic adaptation to stress response signaling. Targeting this pathway may uncover a therapeutic vulnerability specific to metastasis without affecting primary tumor growth.
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S4 from Mitochondrial Glutathione Import Enables Breast Cancer Metastasis via Integrated Stress Response Signaling
Spatial metabolomics of metastatic breast cancers
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Mitochondrial Glutathione Import Enables Breast Cancer Metastasis via Integrated Stress Response Signaling
Spatial metabolomics of metastatic breast cancers
- 31 July 2025
- Published by American Association for Cancer Research (AACR) in Cancer Discovery
- Vol. 15 (12) , 2437-2449
Mitochondrial Glutathione Import Enables Breast Cancer Metastasis via Integrated Stress Response Signaling
Cancer cells require substantial metabolic adaptations to metastasize to distant organs, but the metabolites essential for successful colonization remain poorly defined. In this study, we used a mitochondrial metabolomics approach to compare primary and metastatic breast cancer cells. This analysis revealed accumulation of mitochondrial glutathione (GSH) during lung metastasis, driven by elevated expression of SLC25A39, a mitochondrial GSH transporter. Loss of SLC25A39 impairs metastatic colonization in genetic screens, cell line models, and patient-derived xenografts, without affecting primary tumor growth. Mitochondrial GSH import is specifically required during early colonization and functions independently of its canonical antioxidant role. CRISPR activation screens identified ATF4, a stress-induced transcription factor, as a bypass mechanism that restores metastatic potential in SLC25A39-deficient cells. Mechanistically, SLC25A39 is required for optimal ATF4 activation during metastasis and under hypoxia, linking mitochondrial GSH availability to integrated stress response signaling. These findings identify mitochondrial GSH as a necessary and limiting metabolite for metastatic progression. Significance: Mitochondrial GSH import via SLC25A39 is essential for early metastatic colonization in breast cancer, linking metabolic adaptation to stress response signaling. Targeting this pathway may uncover a therapeutic vulnerability specific to metastasis without affecting primary tumor growth.
- 31 July 2025
- Published by American Association for Cancer Research (AACR) in Cancer Discovery
- Vol. 15 (12) , 2437-2449
Mitochondrial Glutathione Import Enables Breast Cancer Metastasis via Integrated Stress Response Signaling
Cancer cells require substantial metabolic adaptations to metastasize to distant organs, but the metabolites essential for successful colonization remain poorly defined. In this study, we used a mitochondrial metabolomics approach to compare primary and metastatic breast cancer cells. This analysis revealed accumulation of mitochondrial glutathione (GSH) during lung metastasis, driven by elevated expression of SLC25A39, a mitochondrial GSH transporter. Loss of SLC25A39 impairs metastatic colonization in genetic screens, cell line models, and patient-derived xenografts, without affecting primary tumor growth. Mitochondrial GSH import is specifically required during early colonization and functions independently of its canonical antioxidant role. CRISPR activation screens identified ATF4, a stress-induced transcription factor, as a bypass mechanism that restores metastatic potential in SLC25A39-deficient cells. Mechanistically, SLC25A39 is required for optimal ATF4 activation during metastasis and under hypoxia, linking mitochondrial GSH availability to integrated stress response signaling. These findings identify mitochondrial GSH as a necessary and limiting metabolite for metastatic progression. Significance: Mitochondrial GSH import via SLC25A39 is essential for early metastatic colonization in breast cancer, linking metabolic adaptation to stress response signaling. Targeting this pathway may uncover a therapeutic vulnerability specific to metastasis without affecting primary tumor growth.